In this Q&A, Craig Crews, PhD, discusses the discovery and development of proteolysis targeting chimeras, a new modality that is being explored for both drug discovery and therapeutic application
Strong biosafety culture starts with people, not paperwork. Learn how engagement, critical thinking, and continuous training help labs move beyond SOPs to reduce risk and protect staff
Manual processing of samples can burden lab productivity. The innovative Magnis system automates the process across research for cancer, inherited disorders, and infectious disease
Drawing on a career spanning R&D, operations, and executive roles, Todd McEvoy, PhD, offers insights into the mindset and skills needed to succeed in senior leadership